Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), Application (Obsessive Compulsive Disorder, Parkinson’s Disease, Essential Tremor, Epilepsy, Dystonia), Type (Rechargeable, Non-Rechargeable), End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic), Country (U.S., Canada, Mexico)
Some of the major factors contributing to the growth of the market are:
• Rising number of neurological disorder cases
• Increasing healthcare expenditure
Market Players:
The key market players for North America deep brain stimulation systems market are listed below:
• Medtronic
• Boston Scientific Corporation
• Abbott
• Aleva Neurotherapeutics SA
• Neuropace, Inc.
• Beijing Pins Medical Co., Ltd.
• Sceneray Corporation, Limited
• Fisher Wallace
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 EPIDEMIOLOGY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING CASES OF NEUROLOGICAL DISORDERS
6.1.2 GROWING ACCEPTANCE OF MINIMALLY INVASIVE PROCEDURES
6.1.3 RISE IN NUMBER OF PRODUCTS SEEKING APPROVAL
6.1.4 IMPROVES QUALITY OF LIFE AND REDUCES THE DISEASE SYMPTOMS
6.2 RESTRAINTS
6.2.1 HIGH COST OF DEEP BRAIN STIMULATION DEVICES AND SURGERY
6.2.2 STRICT REGULATIONS
6.2.3 POST-OPERATIVE LIMITATIONS OF DEEP BRAIN STIMULATION SYSTEMS
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENT IN NOVEL TECHNOLOGIES
6.3.2 INCREASING HEALTHCARE EXPENDITURE FOR NEUROLOGICAL DISORDERS
6.3.3 MEDICAL TOURISM
6.3.4 EMERGING ECONOMY
6.4 CHALLENGES
6.4.1 HIGH RISK AND COMPLICATIONS OF DEEP BRAIN STIMULATION SURGERY
6.4.2 LOW ACCEPTANCE AMONG PATIENTS
6.4.3 MALFUNCTION OF THE STIMULATOR
7 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE
1.1. OVERVIEW
7.1.1 SINGLE-CHANNEL DEEP BRAIN STIMULATOR
7.1.2 DUAL CHANNEL DEEP BRAIN STIMULATOR
8 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION
8.1 OVERVIEW
8.1.1 PARKINSON’S DISEASE
8.1.2 ESSENTIAL TREMOR
8.1.3 DYSTONIA
8.1.4 EPILEPSY
8.1.5 OBSESSIVE-COMPULSIVE DISORDER
9 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE
9.1 OVERVIEW
9.1.1 RECHARGEABLE
9.1.2 NON-RECHARGEABLE
10 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER
10.1 OVERVIEW
10.1.1 HOSPITALS
10.1.2 NEUROLOGICAL CLINIC
10.1.3 AMBULATORY SURGICAL CENTERS (ASC'S)
11 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 COMPANY PROFILE
13.1 MEDTRONIC
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENT
13.2 BOSTON SCIENTIFIC CORPORATION
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 ABBOTT
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENT
13.4 ALEVA NEUROTHERAPEUTICS SA
13.4.1 COMPANY SNAPSHOT
13.4.2 PRODUCT PORTFOLIO
13.4.3 RECENT DEVELOPMENT
13.5 NEUROPACE, INC.
13.5.1 COMPANY SNAPSHOT
13.5.2 PRODUCT PORTFOLIO
13.5.3 RECENT DEVELOPMENT
13.6 BEIJING PINS MEDICAL CO., LTD.
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 SCENERAY CORPORATION, LIMITED
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 FISHER WALLACE
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
14 SWOT ANALYSIS
15 QUESTIONNAIRE
16 RELATED REPORTS
UU
TABLE 1 CLINICAL TRIAL FOR NEUROLOGICAL DISORDER
TABLE 2 CLINICAL TRIALS BY COUNTRY OF ORIGIN
TABLE 3 SYMPTOMS WHICH CAN BE REDUCE BY THE DEEP BRAIN STIMULATION SURGERY
TABLE 4 TOP MEDICAL TOURISM DESTINATIONS AROUND THE WORLD
TABLE 5 TREATMENT COST IN INDIA AND OTHER COUNTRIES
TABLE 6 SURGERY RISKS
TABLE 7 POSSIBLE SIDE EFFECTS AFTER SURGERY
TABLE 8 POSSIBLE SIDE EFFECTS OF STIMULATION
TABLE 9 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 10 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (UNITS)
TABLE 11 NORTH AMERICA SINGLE-CHANNEL DEEP BRAIN STIMULATOR IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 12 NORTH AMERICA DUAL CHANNEL DEEP BRAIN STIMULATOR IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 14 NORTH AMERICA PARKINSON’S DISEASE IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 NORTH AMERICA ESSENTIAL TREMOR IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 16 NORTH AMERICA DYSTONIA IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 17 NORTH AMERICA EPILEPSY IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 NORTH AMERICA OBSESSIVE-COMPULSIVE DISORDER IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 20 NORTH AMERICA RECHARGEABLE IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 21 NORTH AMERICA NON-RECHARGEABLE IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 23 NORTH AMERICA HOSPITALS IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 24 NORTH AMERICA NEUROLOGICAL CLINIC IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN DEEP BRAIN STIMULATION SYSTEMS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 27 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 28 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (UNITS)
TABLE 29 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 30 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 31 NORTH AMERICA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 32 U.S. DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 33 U.S. DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (UNITS)
TABLE 34 U.S. DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 35 U.S. DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 36 U.S. DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 37 CANADA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027(USD MILLION)
TABLE 38 CANADA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (UNITS)
TABLE 39 CANADA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 40 CANADA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 41 CANADA DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 42 MEXICO DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 43 MEXICO DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE, 2018-2027 (UNITS)
TABLE 44 MEXICO DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 45 MEXICO DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 46 MEXICO DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER, 2018-2027 (USD MILLION)
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...